{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T18:18:55Z","timestamp":1774376335938,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11096-020-01061-w","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T04:07:49Z","timestamp":1590811669000},"page":"1270-1277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacotherapy\u00a0and inappropriate prescriptions in patients with psoriasis"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4245-0101","authenticated-orcid":false,"given":"Luis Fernando","family":"Valladales-Restrepo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-0936","authenticated-orcid":false,"given":"Jorge Enrique","family":"Machado-Alba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,30]]},"reference":[{"issue":"7","key":"1061_CR1","doi-asserted-by":"publisher","first-page":"ITC49","DOI":"10.7326\/AITC201804030","volume":"168","author":"LM Psoriasis","year":"2018","unstructured":"Psoriasis LM. Ann Intern Med. 2018;168(7):ITC49\u2013ITC64.","journal-title":"Ann Intern Med."},{"key":"1061_CR2","first-page":"87","volume":"7","author":"DM Balak","year":"2017","unstructured":"Balak DM, Hajdarbegovic E. Drug-induced psoriasis: clinical perspectives. Psoriasis (Auckl). 2017;7:87\u201394.","journal-title":"Psoriasis (Auckl)"},{"key":"1061_CR3","doi-asserted-by":"publisher","first-page":"4371471","DOI":"10.1155\/2018\/4371471","volume":"2018","author":"A Mohd Affandi","year":"2018","unstructured":"Mohd Affandi A, Khan I, Ngah SN. Epidemiology and clinical features of adult patients with Psoriasis in Malaysia: 10-year review from the Malaysian psoriasis registry (2007\u20132016). Dermatol Res Pract. 2018;2018:4371471.","journal-title":"Dermatol Res Pract"},{"issue":"2","key":"1061_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.det.2018.11.001","volume":"37","author":"S von Csiky-Sessoms","year":"2019","unstructured":"von Csiky-Sessoms S, Lebwohl M. What's new in Psoriasis. Dermatol Clin. 2019;37(2):129\u201336.","journal-title":"Dermatol Clin"},{"issue":"10","key":"1061_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ad.2011.03.022","volume":"102","author":"F Valenzuela","year":"2011","unstructured":"Valenzuela F, Silva P, Vald\u00e9s MP, Papp K. Epidemiology and quality of life of patients with Psoriasis in Chile. Actas Dermosifiliogr. 2011;102(10):810\u20136.","journal-title":"Actas Dermosifiliogr"},{"issue":"3","key":"1061_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cpm.2016.02.004","volume":"33","author":"SM Schleicher","year":"2016","unstructured":"Schleicher SM. Psoriasis: pathogenesis, assessment, and therapeutic update. Clin Podiatr Med Surg. 2016;33(3):355\u201366.","journal-title":"Clin Podiatr Med Surg"},{"issue":"2","key":"1061_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1346-8138.2009.00777.x","volume":"37","author":"N Al-Mutairi","year":"2010","unstructured":"Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol. 2010;37(2):146\u201355.","journal-title":"J Dermatol"},{"issue":"3","key":"1061_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","volume":"50","author":"Y Deng","year":"2016","unstructured":"Deng Y, Chang C, Lu Q. The inflammatory response in psoriasis: a comprehensive review. Clin Rev Allergy Immunol. 2016;50(3):377\u201389.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"1061_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377\u201385.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1061_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/01.ASW.0000550592.08674.43","volume":"32","author":"A Brandon","year":"2019","unstructured":"Brandon A, Mufti A, Gary SR. Diagnosis and management of cutaneous psoriasis: a review. Adv Skin Wound Care. 2019;32(2):58\u201369.","journal-title":"Adv Skin Wound Care"},{"issue":"1","key":"1061_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","volume":"80","author":"SB Kaushik","year":"2019","unstructured":"Kaushik SB, Lebwohl MG. Psoriasis: which therapy for which patient\u2014Psoriasis comorbidities and preferred systemic agents. J Am Acad Dermatol. 2019;80(1):27\u201340.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1061_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jaad.2017.10.012","volume":"78","author":"B Strober","year":"2018","unstructured":"Strober B, Karki C, Mason M, Guo N, Holmgren SH, Greenberg JD, et al. Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: results from the Corrona Psoriasis Registry. J Am Acad Dermatol. 2018;78(2):323\u201332.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1061_CR13","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.jaad.2018.12.037","volume":"80","author":"A Dhana","year":"2019","unstructured":"Dhana A, Yen H, Yen H, Cho E. All-cause and cause-specific mortality in psoriasis: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(5):1332\u2013433.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1061_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/bjd.13013","volume":"171","author":"AB Kimball","year":"2014","unstructured":"Kimball AB, Leonardi C, Stahle M, Gulliver W, Chevrier M, Fakharzadeh S, et al. Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR). Br J Dermatol. 2014;171(1):137\u201347.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1061_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","volume":"60","author":"A Menter","year":"2009","unstructured":"Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60(4):643\u201359.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1061_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","volume":"61","author":"A Menter","year":"2009","unstructured":"Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009;61(3):451\u201385.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"1061_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ijd.14471","volume":"58","author":"N Kogan","year":"2019","unstructured":"Kogan N, Raimondo N, Gusis SE, Izcovich A, Abarca Duran JA, Barahona-Torres L, et al. Latin American clinical practice guidelines on the systemic treatment of psoriasis SOLAPSO - Sociedad Latinoamericana de Psoriasis (Latin American Psoriasis Society). Int J Dermatol. 2019;58(Suppl 1):4\u201328.","journal-title":"Int J Dermatol"},{"issue":"4","key":"1061_CR18","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80(4):1029\u201372.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1061_CR19","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/bjd.15665","volume":"177","author":"CH Smith","year":"2017","unstructured":"Smith CH, Jabbar-Lopez ZK, Yiu ZZ, Bale T, Burden AD, Coates LC, et al. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017. Br J Dermatol. 2017;177(3):628\u201336.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1061_CR20","first-page":"32","volume":"3","author":"GK Kim","year":"2010","unstructured":"Kim GK, Del Rosso JQ. Drug-provoked psoriasis: is it drug induced or drug aggravated? understanding pathophysiology and clinical relevance. J Clin Aesthet Dermatol. 2010;3(1):32\u20138.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"1061_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15569520500536568","volume":"25","author":"E Dika","year":"2006","unstructured":"Dika E, Varotti C, Bardazzi F, Maibach HI. Drug-induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score. Cutan Ocul Toxicol. 2006;25(1):1\u201311.","journal-title":"Cutan Ocul Toxicol"},{"issue":"1","key":"1061_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/15569520701863829","volume":"27","author":"M Hauben","year":"2008","unstructured":"Hauben M, Reich L, Magliano S, Song A. Drug-induced psoriasis: results from pharmacovigilance tools under investigation. Cutan Ocul Toxicol. 2008;27(1):55\u20139.","journal-title":"Cutan Ocul Toxicol"},{"issue":"1","key":"1061_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1177\/247553031218a00101","volume":"18","author":"J Hong","year":"2012","unstructured":"Hong J, Bernstein D. A Review of Drugs that Induce or Exacerbate Psoriasis. Psoriasis Forum. 2012;18(1):2\u201311.","journal-title":"Psoriasis Forum"},{"issue":"5","key":"1061_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ad.2018.10.015","volume":"110","author":"JM Fern\u00e1ndez-Armenteros","year":"2019","unstructured":"Fern\u00e1ndez-Armenteros JM, G\u00f3mez-Arbon\u00e9s X, Buti-Sol\u00e9 M, Betriu-Bars A, Sanmartin-Novell V, Ortega-Bravo M, et al. Epidemiology of Psoriasis a population-based study. Actas Dermosifiliogr. 2019;110(5):385\u201392.","journal-title":"Actas Dermosifiliogr"},{"issue":"5","key":"1061_CR25","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1365-2133.2010.09897.x","volume":"159","author":"S Gerdes","year":"2008","unstructured":"Gerdes S, Zahl VA, Knopf H, Weichenthal M, Mrowietz U. Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. Br J Dermatol. 2008;159(5):1116\u201323.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1061_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2340\/00015555-2877","volume":"98","author":"JH Han","year":"2018","unstructured":"Han JH, Lee JH, Han KD, Seo HM, Bang CH, Park YM, et al. Epidemiology and medication trends in patients with psoriasis: a nationwide population-based cohort study from Korea. Acta Derm Venereol. 2018;98(4):396\u2013400.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"1061_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaad.2010.11.055","volume":"65","author":"A Menter","year":"2011","unstructured":"Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011;65(1):137\u201374.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1061_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/1203475416655705","volume":"20","author":"Canadian Psoriasis Guidelines Addendum Committee","year":"2016","unstructured":"Canadian Psoriasis Guidelines Addendum Committee. Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis. J Cutan Med Surg. 2016;20(5):375\u201343131.","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"1061_CR29","doi-asserted-by":"publisher","first-page":"462","DOI":"10.5021\/ad.2017.29.4.462","volume":"29","author":"HJ Song","year":"2017","unstructured":"Song HJ, Park CJ, Kim TY, Choe YB, Lee SJ, Kim NI, et al. The clinical profile of patients with Psoriasis in Korea: A nationwide cross-sectional study (EPI-PSODE). Ann Dermatol. 2017;29(4):462\u201370.","journal-title":"Ann Dermatol"},{"issue":"1","key":"1061_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/bjd.17074","volume":"180","author":"MT Svendsen","year":"2019","unstructured":"Svendsen MT, Ernst MS, Andersen KE, Andersen F, Johannessen H, Pottegard A. Use of topical antipsoriatic drugs in Denmark: a nationwide drug utilization study. Br J Dermatol. 2019;180(1):157\u201364.","journal-title":"Br J Dermatol"},{"issue":"9","key":"1061_CR31","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamadermatol.2014.1019","volume":"150","author":"AW Armstrong","year":"2014","unstructured":"Armstrong AW. Psoriasis provoked or exacerbated by medications: identifying culprit drugs. JAMA Dermatol. 2014;150(9):963.","journal-title":"JAMA Dermatol"},{"issue":"5","key":"1061_CR32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/0973-3698.272159","volume":"14","author":"S Dogra","year":"2019","unstructured":"Dogra S, Kamat D. Drug-induced psoriasis. Indian J Rheumatol. 2019;14(5):37\u2013433.","journal-title":"Indian J Rheumatol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01061-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-020-01061-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01061-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T18:23:18Z","timestamp":1696184598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-020-01061-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,30]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1007\/s11096-020-01061-w","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,30]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}